pRK5-myc-RhoA-T19N Citations (6)
Originally described in: Bokoch Lab GTPasesUnpublished
Articles Citing pRK5-myc-RhoA-T19N
Articles |
---|
Parathyroid hormone regulation of hypoxia-inducible factor signaling in osteoblastic cells. Wong A, Loots GG, Yellowley CE, Dose AC, Genetos DC. Bone. 2015 Jul 4;81:97-103. doi: 10.1016/j.bone.2015.07.002. PubMed |
Pyk2 Signaling through Graf1 and RhoA GTPase Is Required for Amyloid-beta Oligomer-Triggered Synapse Loss. Lee S, Salazar SV, Cox TO, Strittmatter SM. J Neurosci. 2019 Mar 6;39(10):1910-1929. doi: 10.1523/JNEUROSCI.2983-18.2018. Epub 2019 Jan 9. PubMed |
Lovastatin attenuates angiotensin II induced cardiovascular fibrosis through the suppression of YAP/TAZ signaling. Wu P, Liu Z, Zhao T, Xia F, Gong L, Zheng Z, Chen Z, Yang T, Duan Q. Biochem Biophys Res Commun. 2019 May 14;512(4):736-741. doi: 10.1016/j.bbrc.2019.03.158. Epub 2019 Mar 27. PubMed |
GPR56 Drives Colorectal Tumor Growth and Promotes Drug Resistance through Upregulation of MDR1 Expression via a RhoA-Mediated Mechanism. Zhang S, Chatterjee T, Godoy C, Wu L, Liu QJ, Carmon KS. Mol Cancer Res. 2019 Nov;17(11):2196-2207. doi: 10.1158/1541-7786.MCR-19-0436. Epub 2019 Aug 23. PubMed |
Proline-rich tyrosine kinase 2 mediates transforming growth factor-beta-induced hepatic stellate cell activation and liver fibrosis. Kim J, Kang W, Kang SH, Park SH, Kim JY, Yang S, Ha SY, Paik YH. Sci Rep. 2020 Dec 3;10(1):21018. doi: 10.1038/s41598-020-78056-0. PubMed |
Neuropathy-causing TRPV4 mutations disrupt TRPV4-RhoA interactions and impair neurite extension. McCray BA, Diehl E, Sullivan JM, Aisenberg WH, Zaccor NW, Lau AR, Rich DJ, Goretzki B, Hellmich UA, Lloyd TE, Sumner CJ. Nat Commun. 2021 Mar 4;12(1):1444. doi: 10.1038/s41467-021-21699-y. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.